glp 1 mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Glucagon-Like Peptide-1: New Regulator in
Description
Learn the science behind Ozempic, Wegovy, and more.
Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.
22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide
This study demonstrated that the long-acting GLP-1R agonist, NLY01, has different health benefits in two different mouse models of MS
Imitation drugs, unexpected benefits, serious pitfallsheres what comes next as GLP-1 medications continue to rise in popularity
Yi, a bariatric surgeon, cuts through the noise on GLP-1 medications for men
